218 related articles for article (PubMed ID: 30685648)
21. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
22. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
[TBL] [Abstract][Full Text] [Related]
23. Characterization of neoplastic cells outlining the cystic space of invasive micropapillary carcinoma of the canine mammary gland.
Rodrigues MA; Caldeira-Brant AL; Gomes DA; Silveira TL; Chiarini-Garcia H; Cassali GD
BMC Vet Res; 2021 Mar; 17(1):130. PubMed ID: 33761962
[TBL] [Abstract][Full Text] [Related]
24. Co-localization of chondromodulin-I (ChM-I) and bone morphogenetic protein-6 (BMP-6) in myoepithelial cells of canine mammary tumors.
Kawabata A; Okano K; Uchida K; Yamaguchi R; Hayashi T; Tateyama S
J Vet Med Sci; 2005 Nov; 67(11):1097-102. PubMed ID: 16327219
[TBL] [Abstract][Full Text] [Related]
25. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study.
Ozolek JA; Barnes EL; Hunt JL
Arch Pathol Lab Med; 2007 Apr; 131(4):530-7. PubMed ID: 17425380
[TBL] [Abstract][Full Text] [Related]
26. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
Saraiva AL; Gärtner F; Pires MA
Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Hyperplasia, Neoplasia and Supporting Stroma.
Levi M; Brunetti B; Sarli G; Benazzi C
J Comp Pathol; 2016 Nov; 155(4):277-285. PubMed ID: 27528038
[TBL] [Abstract][Full Text] [Related]
28. Calponin expression and myoepithelial cell differentiation in canine, feline and human mammary simple carcinomas.
Martín de las Mulas J; Reymundo C; Espinosa de los Monteros A; Millán Y; Ordás J
Vet Comp Oncol; 2004 Mar; 2(1):24-35. PubMed ID: 19379308
[TBL] [Abstract][Full Text] [Related]
29. Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells.
Noguchi S; Araki M; Nakajima K; Koh M; Kokado Y; Kubo Y; Otsuka H; Yasuda A; Yokosuka M; Soeta S
J Comp Pathol; 2019 Nov; 173():30-40. PubMed ID: 31812171
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumours and duct ectasias.
Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC
Vet Q; 1993 Sep; 15(3):89-95. PubMed ID: 7505510
[TBL] [Abstract][Full Text] [Related]
32. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.
Xu Z; Wang W; Deng CX; Man YG
Int J Biol Sci; 2009; 5(1):82-96. PubMed ID: 19173015
[TBL] [Abstract][Full Text] [Related]
33. Myoepithelial cells in canine mammary tumours.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J
Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832
[TBL] [Abstract][Full Text] [Related]
34. Biphasic Feline Mammary Carcinomas Including Carcinoma and Malignant Myoepithelioma.
Sammarco A; Finesso G; Zanetti R; Ferro S; Rasotto R; Caliari D; Goldschmidt MH; Orvieto E; Castagnaro M; Cavicchioli L; Zappulli V
Vet Pathol; 2020 May; 57(3):377-387. PubMed ID: 32100640
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
36. The usefulness of p63 as a marker of breast myoepithelial cells.
Batistatou A; Stefanou D; Arkoumani E; Agnantis NJ
In Vivo; 2003; 17(6):573-6. PubMed ID: 14758723
[TBL] [Abstract][Full Text] [Related]
37. p63 and CD10: reliable markers in discriminating benign sclerosing lesions from tubular carcinoma of the breast?
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Alvarenga M; Vassallo J
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):71-7. PubMed ID: 16540734
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
39. Steroid receptors in canine and human female genital tract tumours with smooth muscle differentiation.
Millán Y; Gordon A; de los Monteros AE; Reymundo C; de las Mulas JM
J Comp Pathol; 2007; 136(2-3):197-201. PubMed ID: 17362977
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
